primary renal synovial sarcomas dissected at Tumor Hospital of Linyi City, Shandong. Ultrasound and computed tomography (CT) showed kidney masses in all 4 patients, and 3 were on the left, 1 was on the right. Clinical symptoms included lower back pain and hematuria. The tumors were large with an average diameter of 12 cm (1015 cm), gray crosssection, tenacious texture, hemorrhage, and necrosis. Small cysts with smooth inner walls were found in 3 tumors, which was different in number and unlike the pseudocyst of tumor necrosis. One patient had renal hilum.
The tumors were fixed by 10% neutral buffered formalin and conventionally treated for histologic examination. Clinical data and all histopathologic sections were reviewed, of which the representative ones were prepared for immunohistochemical staining. The EnVision twostep method was performed for immunohistochemical staining, and antibodies included: cytokeratin (CK) (AE1/AE3, Dako, 1:80), EMA (E29, Dako, 1: 100), Vimentin (V9, Dako, 1:100), CD34 (Dako, 1:20) , S100 (Dako, 1:800), SMA (1A4, SigmaChemical, 1:1600), Desmin (D33, Dako, 1:100), CD99 (12E7, Dako, 1:50) , Bcl2 (, Dako, 1: 20) , CD117 (KIT, Dako, 1:300), CD56 (novocastra, 1:50), progesterone receptor (PR) (Biogenex, 1:40) , and estrogen receptor (ER) (Biogenex, 1:50) . Molecular analysis was performed in 2 cases by reverse transcriptase polymerase chain reaction (RTPCR) to detect SYTSSX gene fusion according to ref. 22. All patients underwent radical surgery and were followed up by telephone.
The tumor border was relatively clear, and no capsule was detected. Under highpowered microscopy, the tumor comprised fusiform, round or oval cells as solid sheets or fascicular arrangements, which was characteristic of fusiform, round or oval nuclei, lightstained chromatin, and less cytoplasm ( Figure 1A ). The mitotic phase was 510 mitoses/10 highpower fields (HPF). In some regions, rich and rarefied areas of cells were mixed, and the stroma of the rarefied area showed as mucus ( Figure 1B ). Focal hemorrhage and necrosis were detected, as well as hemangiopericytomashaped structures in all 4 cases ( Figure  1C ). Multiple small cysts of different sizes were scattered in 3 cases, whose inner walls were covered with flat, cube, or spikeshaped cells ( Figure 1D ). Occasionally, the renal tubule and fatty tissue were wrapped around the tumor. In immunohistochemical staining, diffuse expression of Vimentin, CD99, and Bcl2 ( Figure 2A , 2B) were detected in the tumor cells. Moreover, 3 cases showed focal expressions of CD56, CK, and EMA. The epithelial lining of the cysts expressed EMA and CK ( Figure 2C ). S100, CD34, Desmin, Actin, PR, ER, and CD117 were not expressed in the tumor cells.
Molecular analysis of SSXSYT gene fusion was performed in 2 cases, and the result showed SYTSSX1 gene fusion in both cases ( Figure 3 ). Of these 4 patients with primary renal synovial sarcoma, 1 patient reported multiple hepatic metastases postoperatively, and died 13 months after surgery. Lung metastasis was found in 1 patient 6 months after surgery, who died 5 months later. The other 2 patients had disease recurrence 8 and 15 months after surgery, and died at 18 and 21 months, respectively.
Although the origin is unknown, synovial sarcoma is a welldefined clinical and pathologic tumor type that mainly develops in juxtaarticular soft tissue or in the limbs of young people and adults 1 . Synovial sarcoma has 3 histologic subtypes: unidirectional, bidirectional, and poorly differentiated. Because of epithelial and spindlecell components, bidirectional differentiated synovial sarcoma is easy to diagnose; but sometimes it is difficult to distinguish unidirectional synovial sarcoma from other spindlecell sarcomas.
Primary renal synovial sarcoma needs to be differentially diagnosed from leiomyosarcoma, fibrosarcoma, malignant peripheral nerve sheath tumors, primitive neuroectodermal tumors, solitary fibrous tumors, hemangiopericytoma, mixed epithelial and mesenchymal tumors, Wilm's tumors, and renal sarcomatoid carcinoma. Leiomyosarcoma and fibrosarcoma are also rare in the kidney, and are solid, have no small cysts with a spikeshaped cell lining, and few hemangiopericytomashaped structures, often express SMA, but do not express BCL2, CD99, and CD56.
Hemangiopericytoma and solitary fibrous tumors occasionally occur in the kidney, and only a few cases have been reported 23, 24 . Synovial sarcoma has hemangiopericytomashaped structures, and sometimes it is difficult to discriminate it from hemangiopericytoma and solitary fibrous tumors. However, in synovial sarcoma cells, pleomorphism and heteromorphism are obvious and cells in the mitotic phase are more common. Moreover, lacunules with a spikeshaped cell lining can be observed, while for hemangiopericytoma, the irregular Malignant peripheral nerve sheath tumor (MPNST) is histologically similar to synovial sarcoma, especially when MPNST is accompanied by an adenoid structure (socalled adenoid MPNST). About 50% 70% of MPNST express S100 and synovial sarcoma is usually negative 25 . Although a few MPNSTs express EMA and CD56, they rarely express CK and CD99. In contrast, synovial sarcoma is often CK and CD99positive and NFnegative. Primitive neuroectodermal tumor (PNET) comprises more primitive small cells, and sometimes a rosette structure can be observed. Immunohistochemically, the expressions of CD99 and CD56 are positive, while the expressions of EMA and CK are negative. In this study, the 4 cases all expressed BCL2, Vimentin, EMA, CK, CD99, and CD56, which could exclude MPNST and PNET.
Mixed epithelial and mesenchymal tumor (MEMT), and cystic nephroma (CN) are composed of the spindle cell areas, ovarian stroma, and cysts with epithelial linings, which also need to be identified with synovial sarcoma. And the spindle cell of synovial sarcoma, which is characteristic of obvious heteromorphism and the mitotic phase, is different from the benign mesenchymal components of MEMT and CN. Moreover, the ovarian stroma of MEMT and CN can express Inhibin, PR, and ER 26 . Wilm's tumor occasionally occurs in adults, but the tumor can develop a primordial composition and an immaturely differentiated renal tubule, which is absent in synovial sarcoma. At the same time, Wilm's tumor can express WT1, which is negative in synovial sarcoma.
Sometimes it is difficult to differentiate renal sarcomatoid carcinoma and synovial sarcoma, for sarcomatoid carcinoma also expresses epithelial markers and Vimentin
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. Via multiple sampling, typical cancer areas of sarcomatoid carcinoma is often found, such as clearcell carcinoma components, nippleshaped structures, or carcinous cryptae of obvious heteromorphisms, and the malignant cryptae are different from the remnants of the smalltube or cystic structures of synovial sarcoma, which is not cell atypia. In addition, the sarcomatoid region of sarcomatoid carcinoma does not express CD99 and CD56.
In this study, the carcinogenic ingredient was not found in the 4 cases by extensive sampling. Cysts with cuboidal epithelium or a spikeshaped cell lining are important histologic features of renal synovial sarcoma, and these cystic structures are rarely found in other primary renal sarcomas, such as smooth muscle sarcoma, fibrosarcoma, MPNST, PNET, or sarcomatoid carcinoma. Argani . 28 reported on 15 patients with renal primary synovial sarcoma, where the majority of the tumors had small visible cavities with smooth inner walls, which were different from the pseudocavities of tumor necrosis . Since 1987 , when t (X; 18) translocation was found, this abnormality has been considered as the genomic character of synovial sarcoma, which can be detected in approximately 90% of synovial sarcomas 2931 . Crew . 19 noted that the t (X; 18) (p11.2; q11.2) translocation of synovial sarcomas resulted in the fusion of the SYT gene and one of the homologous genes (SSX1, SSX2) on chromosome 18. This genetic abnormality was found in all synovial sarcoma subtypes, including the bidirectional, the unidirectional, and the poorly differentiated subtypes.
By fluorescence in situ hybridization, Birdsall . 32 found that specific t (X; 18) translocation of synovial sarcoma was detected in both epithelial cells and spindlecell components of 3 bidirectionally differentiated synovial sarcomas, and the results showed that whether bidirectional or unidirectional differentiated synovial sarcoma, tumor cells were monoclonal hyperplasia. In this study, SYTSSX1 gene fusion was detected in both cases where RTPCR was used and the diagnoses were confirmed.
Renal synovial sarcoma is rare and its prognosis is poor. Most patients die within 12 years of tumor recurrence or metastasis. In this study, the longest survival time after surgery was 21 months. Its morphologic and immunohistochemical characteristics may be related to other spindlecell tumors of the kidney. Therefore, diagnosis of primary renal synovial sarcoma needs to exclude other similar diseases and confirm the SYTSSX gene fusion by molecular analysis.
